CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 443 filers reported holding CRISPR THERAPEUTICS AG in Q4 2021. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,228,685 | -28.0% | 115,374 | -10.8% | 0.00% | 0.0% |
| Q2 2023 | $7,258,564 | +92.5% | 129,319 | +55.1% | 0.00% | +100.0% |
| Q1 2023 | $3,771,186 | +61.6% | 83,378 | +45.3% | 0.00% | 0.0% |
| Q4 2022 | $2,333,000 | -66.2% | 57,384 | -45.0% | 0.00% | -66.7% |
| Q3 2022 | $6,895,000 | +91.9% | 104,369 | +76.5% | 0.00% | +200.0% |
| Q2 2022 | $3,593,000 | +6.3% | 59,132 | +9.8% | 0.00% | 0.0% |
| Q1 2022 | $3,379,000 | -2.9% | 53,836 | +17.2% | 0.00% | 0.0% |
| Q4 2021 | $3,480,000 | -90.8% | 45,927 | -86.4% | 0.00% | -91.7% |
| Q3 2021 | $37,687,000 | -30.9% | 336,693 | -0.0% | 0.01% | -29.4% |
| Q2 2021 | $54,520,000 | -4.0% | 336,770 | -27.8% | 0.02% | -10.5% |
| Q1 2021 | $56,819,000 | -17.1% | 466,292 | +3.9% | 0.02% | -20.8% |
| Q4 2020 | $68,501,000 | +30.3% | 448,896 | -28.8% | 0.02% | +14.3% |
| Q3 2020 | $52,583,000 | -32.9% | 630,163 | -40.9% | 0.02% | -38.2% |
| Q2 2020 | $78,383,000 | +126.4% | 1,066,578 | +30.7% | 0.03% | +88.9% |
| Q1 2020 | $34,615,000 | +21.0% | 816,207 | +73.7% | 0.02% | +50.0% |
| Q4 2019 | $28,612,000 | +3294.1% | 469,773 | +2183.7% | 0.01% | – |
| Q3 2019 | $843,000 | -13.2% | 20,571 | -0.2% | 0.00% | – |
| Q2 2019 | $971,000 | +13.8% | 20,608 | -13.7% | 0.00% | – |
| Q1 2019 | $853,000 | +31.6% | 23,887 | +5.4% | 0.00% | – |
| Q4 2018 | $648,000 | -69.9% | 22,673 | -53.3% | 0.00% | -100.0% |
| Q3 2018 | $2,151,000 | -28.2% | 48,500 | -7.4% | 0.00% | 0.0% |
| Q2 2018 | $2,994,000 | +155.7% | 52,402 | +93.1% | 0.00% | 0.0% |
| Q1 2018 | $1,171,000 | – | 27,133 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
| NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
| Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
| ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
| NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
| Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
| Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
| Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
| Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |